Brain Cancer
Scientists in California and Michigan said that their FastGlioma algorithm can improve detection of tumor infiltration at the margins of surgery sites.
FDA Approves Thermo Fisher Oncomine Dx Target Test as CDx for Servier's Voranigo Brain Cancer Drug
The approval expands the clinical indications for the test, which was previously approved as a CDx for non-small cell lung cancer, thyroid cancer, and bile duct cancer drugs.
German Children's Cancer Center Aims to Expand Global Access to Methylation-Based Tumor Classifier
Premium
The program will provide funding and expertise to clinics in low-income countries to run methylation array-based assays to classify central nervous system tumors in children.
Biocept Prices $5M Public Offering
The San Diego-based company plans to use the proceeds to advance its cerebral spinal fluid liquid biopsy assay, as well as to boost its working capital.
Dxcover Raises $11.9M to Bring Infrared Spectroscopy Cancer Detection Assay to Market
The firm is advancing what it describes as an infrared spectroscopy-based platform for early cancer detection, with initial data in brain tumors.